Bionano Genomics (BNGO) News Today $3.03 -0.33 (-9.82%) Closing price 04:00 PM EasternExtended Trading$3.02 -0.01 (-0.50%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest ResultsApril 3 at 7:17 PM | finance.yahoo.comScotiabank Sticks to Its Hold Rating for BioNano Genomics (BNGO)April 2 at 11:58 PM | markets.businessinsider.comBionano Genomics price target raised to $4 from $1 at ScotiabankApril 2 at 11:58 PM | markets.businessinsider.comBionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call TranscriptApril 1 at 10:43 AM | msn.comBionano Genomics reports Q4 revenue $8.16M vs. $10.72M last yearApril 1 at 5:42 AM | markets.businessinsider.comBionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilizationApril 1 at 12:42 AM | msn.comBionano Genomics (BNGO) Q4 2024 Earnings Call TranscriptApril 1 at 12:42 AM | msn.comBionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comBionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025March 31, 2025 | globenewswire.com3BNGO : What's Next: Bionano Genomics's Earnings PreviewMarch 28, 2025 | benzinga.comBionano Genomics and Greenwood Genetic Center Publish Study Using Optical Genome Mapping to Advance Understanding of Neural Tube DefectsMarch 26, 2025 | nasdaq.comBionano Genomics announces publication on study using OGMMarch 25, 2025 | markets.businessinsider.comStudy Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth DefectMarch 24, 2025 | globenewswire.comBionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual MeetingMarch 18, 2025 | globenewswire.comBionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025March 14, 2025 | globenewswire.comBionano Genomics: Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AMLMarch 13, 2025 | finanznachrichten.deBionano Genomics announces publication reporting first use of OGM to detect CAGMarch 13, 2025 | markets.businessinsider.comBionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AMLMarch 13, 2025 | globenewswire.comBionano Genomics stock hits 52-week low at $4.9 amid sharp declineFebruary 3, 2025 | msn.comBionano Genomics, Inc. (NASDAQ:BNGO) Short Interest UpdateBionano Genomics, Inc. (NASDAQ:BNGO - Get Free Report) was the target of a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 341,500 shares, a decline of 98.1% from the December 31st total of 17,650,000 shares. Approximately 14.7% of the shares of the company are short sold. Based on an average trading volume of 143,900 shares, the short-interest ratio is presently 2.4 days.January 31, 2025 | marketbeat.comBionano Genomics (NASDAQ:BNGO) Trading Up 5.5% - Still a Buy?Bionano Genomics (NASDAQ:BNGO) Trading Up 5.5% - Here's What HappenedJanuary 29, 2025 | marketbeat.comBionano Genomics (NASDAQ:BNGO) Shares Gap Down - Here's WhyBionano Genomics (NASDAQ:BNGO) Shares Gap Down - Here's WhyJanuary 28, 2025 | marketbeat.comBioNano Genomics Executes Significant Reverse Stock SplitJanuary 27, 2025 | msn.comBionano Genomics (NASDAQ:BNGO) Sets New 12-Month Low - Here's What HappenedBionano Genomics (NASDAQ:BNGO) Sets New 1-Year Low - Time to Sell?January 27, 2025 | marketbeat.comBionano Genomics trading halted, news pendingJanuary 25, 2025 | markets.businessinsider.comBionano Genomics stock hits 52-week low at $0.17 amid market challengesJanuary 23, 2025 | msn.comBionano Genomics: Bionano Announces Effective Date of Reverse Stock SplitJanuary 23, 2025 | finanznachrichten.deBionano Genomics announces 1-for-60 reverse stock splitJanuary 23, 2025 | msn.comBionano Announces Effective Date of Reverse Stock SplitJanuary 22, 2025 | globenewswire.comBionano Genomics shareholders approve stock issuance and reverse splitJanuary 16, 2025 | msn.comBionano Genomics announces use of OGM in preimplantation genetic testingJanuary 14, 2025 | markets.businessinsider.comBionano Genomics reports preliminary Q4 revenue $7.9M-$8.1M, consensus $6.3MJanuary 14, 2025 | markets.businessinsider.comBionano Reports Preliminary Fourth Quarter and Full-Year 2024 ResultsJanuary 13, 2025 | finance.yahoo.comBionano Genomics announces publication on OGM for AMLJanuary 7, 2025 | markets.businessinsider.comBionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic LeukemiaJanuary 7, 2025 | finance.yahoo.comBionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesJanuary 6, 2025 | globenewswire.comBionano sells 39.68M shares at 25.2c in registered direct offeringJanuary 4, 2025 | markets.businessinsider.comBionano Genomics files to sell 50.56M share of common stock for holdersJanuary 4, 2025 | markets.businessinsider.comBionano stock rallies 19% on ATM direct offeringJanuary 4, 2025 | msn.comBionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesJanuary 3, 2025 | globenewswire.comBionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash RunwayDecember 31, 2024 | globenewswire.comBionano Genomics announces publication in Modern Pathology on OGMDecember 23, 2024 | markets.businessinsider.comBionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor AnalysisDecember 23, 2024 | globenewswire.comBionano Genomics urges stockholders to support proposals at special meetingDecember 19, 2024 | markets.businessinsider.comBionano Genomics announces presentations at ASH annual meetingDecember 11, 2024 | markets.businessinsider.comHold Rating on BioNano Genomics Amid Revenue Shortfall and Strategic ShiftNovember 19, 2024 | markets.businessinsider.comLadenburg downgrades Bionano Genomics on restructuring uncertaintyNovember 16, 2024 | markets.businessinsider.comScotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)November 16, 2024 | markets.businessinsider.comBionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comLadenburg Thalmann Downgrades Bionano Genomics (BNGO)November 16, 2024 | msn.com Remove Ads Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address BNGO Media Mentions By Week BNGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNGO News Sentiment▼0.200.61▲Average Medical News Sentiment BNGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNGO Articles This Week▼112▲BNGO Articles Average Week Remove Ads Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DAIO News AXDX News ASTC News STAI News PRPO News TBIO News SMIT News SPEC News TT News KEYS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNGO) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.